{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T17:13:57Z","timestamp":1697994837478},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,10,15]]},"DOI":"10.2169\/internalmedicine.1279-22","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T22:11:00Z","timestamp":1677622260000},"page":"2981-2988","source":"Crossref","is-referenced-by-count":0,"title":["Usefulness of Alternative Therapy with Hydrocortisone in the Postoperative Management of Severe Primary Aldosteronism"],"prefix":"10.2169","volume":"62","author":[{"given":"Masahiro","family":"Asakawa","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Takaku","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kawada","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Murata","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Katsuta","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101: 1889-1916, 2016.","DOI":"10.1210\/jc.2015-4061"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hannemann A, Wallaschofski H. Prevalence of primary aldosteronism in patient's cohorts and in population-based studies - a review of the current literature. Horm Metab Res 44: 157-162, 2012.","DOI":"10.1055\/s-0031-1295438"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 66: 607-618, 2007.","DOI":"10.1111\/j.1365-2265.2007.02775.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kawashima A, Sone M, Inagaki N, et al. Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism. Eur J Endocrinol 181: 339-350, 2019.","DOI":"10.1530\/EJE-19-0047"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mulatero P, Monticone S, Bertello C, et al. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab 98: 4826-4833, 2013.","DOI":"10.1210\/jc.2013-2805"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Ohno Y, Sone M, Inagaki N, et al. Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension 71: 530-537, 2018.","DOI":"10.1161\/HYPERTENSIONAHA.117.10263"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48: 2293-2300, 2006.","DOI":"10.1016\/j.jacc.2006.07.059"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Celen O, O'Brien MJ, Melby JC, Beazley RM. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 131: 646-650, 1996.","DOI":"10.1001\/archsurg.1996.01430180072015"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Meyer A, Brabant G, Behrend M. Long-term follow-up after adrenalectomy for primary aldosteronism. World J Surg 29: 155-159, 2005.","DOI":"10.1007\/s00268-004-7496-z"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Rossi GP, Cesari M, Cuspidi C, et al. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension 62: 62-69, 2013.","DOI":"10.1161\/HYPERTENSIONAHA.113.01316"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sawka AM, Young WF, Thompson GB, et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 135: 258-261, 2001.","DOI":"10.7326\/0003-4819-135-4-200108210-00010"},{"key":"12","unstructured":"12. Williams TA, Lenders JWM, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 5: 689-699, 2017."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 8: 293-300, 2012.","DOI":"10.1038\/nrneph.2012.19"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Kobayashi H, Abe M, Nakamura Y, et al. Association between acute fall in estimated glomerular filtration rate after treatment for primary aldosteronism and long-term decline in renal function. Hypertension 74: 630-638, 2019.","DOI":"10.1161\/HYPERTENSIONAHA.119.13131"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Sechi LA, Novello M, Lapenna R, et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA 295: 2638-2645, 2006.","DOI":"10.1001\/jama.295.22.2638"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Chiang WF, Cheng CJ, Wu ST, et al. Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma. Clin Chim Acta 424: 114-118, 2013.","DOI":"10.1016\/j.cca.2013.05.017"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fischer E, Hanslik G, Pallauf A, et al. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy. J Clin Endocrinol Metab 97: 3965-3973, 2012.","DOI":"10.1210\/jc.2012-2234"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Park KS, Kim JH, Ku EJ, et al. Clinical risk factors of postoperative hyperkalemia after adrenalectomy in patients with aldosterone-producing adenoma. Eur J Endocrinol 172: 725-731, 2015.","DOI":"10.1530\/EJE-15-0074"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Huang WT, Chau T, Wu ST, Lin SH. Prolonged hyperkalemia following unilateral adrenalectomy for primary hyperaldosteronism. Clin Nephrol 73: 392-397, 2010.","DOI":"10.5414\/CNP73392"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Arima S, Kohagura K, Xu HL, et al. Nongenomic vascular action of aldosterone in the glomerular microcirculation. J Am Soc Nephrol 14: 2255-2263, 2003.","DOI":"10.1097\/01.ASN.0000083982.74108.54"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fourkiotis VG, Hanslik G, Hanusch F, Lepenies J, Quinkler M. Aldosterone and the kidney. Horm Metab Res 44: 194-201, 2012.","DOI":"10.1055\/s-0031-1295461"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Wada N, Shibayama Y, Umakoshi H, et al. Hyperkalemia in both surgically and medically treated patients with primary aldosteronism. J Hum Hypertens 31: 627-632, 2017.","DOI":"10.1038\/jhh.2017.38"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Utsumi T, Kamiya N, Kaga M, et al. Development of novel nomograms to predict renal functional outcomes after laparoscopic adrenalectomy in patients with primary aldosteronism. World J Urol 35: 1577-1583, 2017.","DOI":"10.1007\/s00345-017-2033-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nakano Y, Yoshimoto T, Fukuda T, et al. Effect of eplerenone on the glomerular filtration rate (GFR) in primary aldosteronism: sequential changes in the GFR during preoperative eplerenone treatment to subsequent adrenalectomy. Intern Med 57: 2459-2466, 2018.","DOI":"10.2169\/internalmedicine.0438-17"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 93: 3266-3281, 2008.","DOI":"10.1210\/jc.2008-0104"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Quinkler M, Stewart PM. Treatment of primary aldosteronism. Best Pract Res Clin Endocrinol Metab 24: 923-932, 2010.","DOI":"10.1016\/j.beem.2010.10.001"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Mattsson C, Young WF Jr. Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol 2: 198-208; quiz, 1 p following 230, 2006.","DOI":"10.1038\/ncpneph0151"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Shariq OA, Bancos I, Cronin PA, et al. Contralateral suppression of aldosterone at adrenal venous sampling predicts hyperkalemia following adrenalectomy for primary aldosteronism. Surgery 163: 183-190, 2018.","DOI":"10.1016\/j.surg.2017.07.034"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Heinrich DA, Adolf C, Holler F, et al. Adrenal insufficiency after unilateral adrenalectomy in primary aldosteronism: long-term outcome and clinical impact. J Clin Endocrinol Metab 104: 5658-5664, 2019.","DOI":"10.1210\/jc.2019-00996"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Wang X, Heinrich DA, Kunz SL, et al. Characteristics of preoperative steroid profiles and glucose metabolism in patients with primary aldosteronism developing adrenal insufficiency after adrenalectomy. Sci Rep 11: 11181, 2021.","DOI":"10.1038\/s41598-021-90901-4"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/20\/62_1279-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T03:25:33Z","timestamp":1697858733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/20\/62_1279-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,15]]},"references-count":30,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1279-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,15]]},"article-number":"1279-22"}}